Your Article Summary
See Latest ArticlesGenetic and clinical factors relating to warfarin dosing
Trends in Pharmacological Sciences, 06/30/09
Jonas DE et al. - Recent studies have reported that polymorphisms in CYP4F2 might account for between 2 and 7% of the variation. Several prospective studies have evaluated genotype-guided dosing, but these have found negative results or were poorly designed.
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Bupivacaine Inhibits Glutamatergic Transmission in Spinal Dorsal Horn Neurons
Anesthesiology, 12/11/09
Expectations, validity, and reality in pharmacogenetics
Journal of Clinical Epidemiology, 12/11/09
Inhibitory effects of 1,3-thiazine derivatives on melanogenesis
Journal of Pharmacy and Pharmacology, 12/10/09
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Clinical Infectious Diseases, 12/11/09
Congenital abnormalities in children of 43 pregnant women who attempted suicide with large doses of nitrazepam
Pharmacoepidemiology and Drug Safety, 12/09/09